Dr. Nathan approves lifestyle in the early, but not the late stages?

In the Los Angeles Times article, Dr. Nathan appeared to not be such a proponent of lifestyle with people during the late stage of the diabetes on insulin.  In Lancet, he is a firm supporter of lifestyle during the early stage of the disease.

The study team, led by Dr. David M. Nathan of Massachusetts General Hospital, reported on the 10-year results this week in the journal Lancet. In the 10 years, participants in the original lifestyle-change group delayed the onset of diabetes by an average of four years compared with the placebo group, and those in the metformin group delayed it by an average of two years. "The benefits of intensive lifestyle changes were especially pronounced in the elderly," Nathan said. "People age 60 and older lowered their rate of developing diabetes in the next 10 years by about half."

Click here for the LA times Link.
--
Dr. Wei-An Andy Lee
Clinical Endocrinologist
Assistant Professor of Clinical Medicine
Keck School of Medicine
University of Southern California

"This email message is confidential, intended only for the recipient(s) named above and
may contain information this is privileged, exempt from disclosure under applicable law.
If you are not the intended recipient, do not disclose or disseminate this message to
anyone except the intended recipient. If you have received this message in error, or are
not the named recipient(s), please immediately notify the sender by return email, and
delete all copies of this message."